Despite what the name suggests, Polyendocrine Metabolic Ovarian Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PMOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PMOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PMOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PMOS so challenging—and why understanding your unique experience matters.
So, how can the PMOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PMOS—and make progress.
Here’s what you’ll find at PMOSA:
✅ Reliable, science-backed information about what PMOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PMOS patients
🙋♀️ Advocacy to make sure PMOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PMOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
CONCLUSIONS: BMI is not a clinically meaningful predictor of ovarian reserve as a continuous variable. Lower AMH in underweight women highlights a subgroup warranting attention in reproductive assessments, while PCOS status does not influence this relationship.
Published on: Tue, 21 Jul 2026 06:00:00 -0400
Authors: Zhen Wang, Yanfei Liu, Yonghai Shen, Lin Ma, Xinyan Shi,
CONCLUSIONS: REPS w/BANDS is feasible and has potential to improve mental and physical health outcomes. Participants reported increased exercise motivation due to rapport with the personal trainer and the personal trainer's PCOS knowledge, use of SDT strategies, and interest in the participants' fitness progress. REPS w/BANDS was revised based on findings and will be piloted as a larger randomized controlled trial.
Published on: Tue, 21 Jul 2026 06:00:00 -0400
Authors: Pamela J Wright, Cynthia F Corbett,
Polycystic Ovary Syndrome (PCOS) is a heterogeneous endocrine-metabolic disorder characterized by ovulatory dysfunction, hyperandrogenism, and insulin resistance, in which mitochondrial dysfunction has been increasingly implicated. Mitochondria regulate energy metabolism and oxidative stress, with mitophagy maintaining cellular balance. Dysregulated mitophagy relates to PCOS metabolic issues like obesity and inflammation. This study analyzed gene expression datasets to find autophagy-related...
Published on: Mon, 20 Jul 2026 06:00:00 -0400
Authors: Aiqin Lian, Yuxin Li, Weijun He, Xinjian Luo, Long Jin, Chaohui Li,
This study employed an integrated strategy of network pharmacology, molecular docking, and in vitro assays in KGN cells to explore the mechanisms of action of Placenta Hominis (PH) in Polycystic Ovary Syndrome (PCOS). We hypothesized that PH (which contains bioactive compounds such as steroid hormones and peptides) exerts its therapeutic effects against PCOS through a multi-target mechanism. Potential targets of PH- and PCOS-related genes were identified in public databases. After network...
Published on: Sun, 19 Jul 2026 06:00:00 -0400
Authors: Haixia Pan, Meilin Wu, Ting Mao, Ziyi Deng, Yingqiao Zhong, Yong Guo, Siyang Chen, Lei Huang, Daopeng Yang, Ying Zhou,
CONCLUSION: Among patients undergoing their first IVF treatment, SII was independently associated with PCOS. This further supported the crucial role of chronic low-grade inflammation in the pathophysiology of PCOS. In the future, its efficacy needs to be verified through large-scale studies. Before it is fully confirmed, it is not recommended to use it as an independent clinical tool.
Published on: Sun, 19 Jul 2026 06:00:00 -0400
Authors: Hui Li, Huaiyun Tang, Mei Wang, Huijuan Guan, Lisha Tang, Xu Chen,
No abstract
Published on: Sat, 18 Jul 2026 06:00:00 -0400
Authors: Nisan Helin Donmez, Hanne Bulat Cim, Esmehan Aysit, Melis Altug Inan, Ergul Demircivi, Abdulkadir Turgut,
Polycystic ovary syndrome (PCOS) is the most prevalent endocrine-metabolic disorder in women of reproductive age, and is characterized by hyperandrogenism, anovulation, and polycystic ovarian morphology. Emerging molecular evidence has identified dysregulated ovarian steroidogenesis as a major contributing mechanism linking reproductive and metabolic phenotypes in PCOS, acting in concert with neuroendocrine and metabolic dysfunction. This review synthesizes current knowledge on enzymatic and...
Published on: Sat, 18 Jul 2026 06:00:00 -0400
Authors: Thirumurugan Ayyadurai, Sasikumar Ravi, Aravinth Annamalai,
CONCLUSION: The study results showed that xerostomia was associated with PCOS and the oral health-related quality of life was affected in these patients. In females diagnosed with PCOS, keeping oral health under control can improve quality of life. It highlights the importance of integrating routine oral health assessments into the standard clinical management of women with PCOS. Healthcare professionals should adopt a multidisciplinary approach to identify and manage oral health problems that...
Published on: Fri, 17 Jul 2026 06:00:00 -0400
Authors: Kübra Karaçam, Rahime Zeynep Erdem, Özlem Gül,
No abstract
Published on: Fri, 17 Jul 2026 06:00:00 -0400
Authors: Qi Zhou, Hong Tang, Yongfeng Wang, Yu Hua, Xiaoling Ouyang, Linxia Li,
CONCLUSION: Although our vegetarian women with PCOS, had normal value of liver enzymes, they were higher in comparison to control groups. SGPT was independently association with insulin resistance (IR), suggesting disturbance of liver enzyme in POCS and inflammatory marker (WBC) were mainly influenced by BMI. The association between AMH and testosterone suggests that hyperandrogenism and ovarian dysfunction in PCOS and may occur independently of adiposity.
Published on: Fri, 17 Jul 2026 06:00:00 -0400
Authors: Foram K Ravat, Sneha M Nair, Mayur Gandhi, Pallavi Ninama, Shital Punjabi, Dhaval Shah, Devang B Sheth, Bhoomika Patel, Bhumika K Maheriy, Kashyap N Thummar,
BACKGROUND: Polycystic ovary syndrome (PCOS), recently renamed polyendocrine metabolic ovarian syndrome (PMOS), is characterised by neuroendocrine dysfunction with accelerated gonadotrophin-releasing hormone (GnRH)/luteinising hormone (LH) pulsatility driving hyperandrogenism and anovulatory infertility.
Published on: Fri, 17 Jul 2026 06:00:00 -0400
Authors: Ludovica Cotellessa, Hélène Maitre, Frank Giton, Silvia Bongiovanni, Pascal Pigny, Geoffroy Robin, Sophie Catteau-Jonard, Paolo Giacobini,
The aim of this study was to present the current state of knowledge regarding the use of the ketogenic diet in the treatment of obesity in adults, with particular emphasis on its safety, indications, and contraindications, and to relate these findings to its established use in drug-resistant epilepsy and other clinical conditions. Despite growing interest in its clinical application, the effectiveness and safety of this intervention remain a matter of debate. A narrative review of the literature...
Published on: Fri, 17 Jul 2026 06:00:00 -0400
Authors: Urszula Kacprzak, Natalia Adamaszek, Agnieszka Buczkowska, Julia Sochowska, Michalina Flejszman, Julia Danieluk, Justyna Wójcik, Laura Stochaj, Michał Gliński, Dominika Dołęga-Mostowska,
Obese polycystic ovary syndrome (PCOS) involves insulin resistance (IR) and impaired endometrial receptivity, potentially driven by hypothalamic inflammation. We investigated if inhibiting the hypothalamic Toll-like receptor 4 (TLR4)/IkappaB kinase beta (IKKbeta) pathway could ameliorate IR and improve endometrial receptivity in an obese PCOS rat model. An obese PCOS rat model was established using letrozole and high-fat diet. Rats were divided into control, PCOS, and three intervention groups:...
Published on: Fri, 17 Jul 2026 06:00:00 -0400
Authors: C Sun, Y Han, Z Pan, J Li, X Cheng, M Sun, Y Wang, H Kuang,
No abstract
Published on: Fri, 17 Jul 2026 06:00:00 -0400
Authors: Bassel H Al Wattar, Sophie Clarke, Rebecca Scott, Rima K Dhillon-Smith,
In women of reproductive age, polycystic ovary syndrome (PCOS) is a widespread endocrine condition that is primarily connected to disrupted lipid metabolism. However, the cell-specific lipidomic signatures and their regulatory mechanisms in ovarian granulosa cells (GCs) of PCOS women remain elusive, particularly across clinical subgroups. We conducted quantitative lipidomics to profile luteinized GC lipid metabolism in PCOS subgroups. Non-overweight PCOS (NOP) patients underwent targeted...
Published on: Fri, 17 Jul 2026 06:00:00 -0400
Authors: Ningning Xie, Jue Zhou, Wenshan Zeng, Paul James Hardiman, Hye Won Lee, Myeong Soo Lee, Fangfang Wang, Fan Qu,